BBL
LLY icon

Beck Bode LLC’s Eli Lilly LLY Stock Holding History

Beck Bode LLC’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,394
Closed -$15.1M – 128
2026
Q1 		$15.1M Buy
+16,394
New +$16.6M 2.55% 24
2025
Q1 		– Sell
-346
Closed -$267K – 122
2024
Q4 		$267K Sell
346
-16,538
-98% -$13.7M 0.05% 100
2024
Q3 		$15M Buy
16,884
+277
+2% +$249K 2.81% 16
2024
Q2 		$15M Buy
+16,607
New +$13.3M 3.02% 6
2023
Q1 		– Sell
-10,246
Closed -$3.75M – 166
2022
Q4 		$3.75M Buy
10,246
+774
+8% +$274K 0.84% 39
2022
Q3 		$3.06M Buy
9,472
+46
+0.5% +$14.6K 0.66% 45
2022
Q2 		$3.06M Buy
+9,426
New +$2.83M 0.65% 43
2021
Q3 		– Sell
-35
Closed -$8K – 196
2021
Q2 		$8K Buy
+35
New +$7.03K ﹤0.01% 239

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Beck Bode LLC's LLY Position: Q2 2026 in Review

Beck Bode LLC sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 16,394 shares — an estimated $15.1M sold.

Beck Bode LLC first reported a position in LLY in Q2 2021 and held it in 8 quarters. The position peaked at $15.1M in Q1 2026. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Beck Bode LLC reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Beck Bode LLC sold 16,394 Eli Lilly shares in Q2 2026, an estimated $15.1M.
  • Beck Bode LLC first reported a position in Eli Lilly in Q2 2021 and held it in 8 quarters.
  • Beck Bode LLC's Eli Lilly position peaked at $15.1M in Q1 2026.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Beck Bode LLC's 13F filing for Q2 2026, filed 13 Aug 2026.